Core Viewpoint - Cisco Systems (CSCO) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are strongly correlated with near-term stock price movements [3][5]. - Institutional investors often rely on earnings estimates to determine a company's fair value, leading to significant stock transactions that affect prices [3]. Cisco's Earnings Outlook - For the fiscal year ending July 2026, Cisco is expected to earn $4.14 per share, which remains unchanged from the previous year, but the Zacks Consensus Estimate has increased by 3.7% over the past three months [7]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [6]. - Only the top 5% of stocks covered by Zacks receive a "Strong Buy" rating, indicating superior earnings estimate revisions [8][9].

Investors might want to bet on Radian (RDN) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changin ...

Domino's Pizza (DPZ) came out with quarterly earnings of $5.35 per share, missing the Zacks Consensus Estimate of $5.38 per share. This compares to earnings of $4.89 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.56%. A quarter ago, it was expected that this pizza chain would post earnings of $3.96 per share when it actually produced earnings of $4.08, delivering a surprise of +3.03%.Over the last four quarters, the compan ...

Freshpet (FRPT) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +47.19%. A quarter ago, it was expected that this seller of refrigerated fresh pet food would post earnings of $0.43 per share when it actually produced earnings of $0.46, delivering a surprise of +6.98%.Over the last fou ...

Lincoln Educational Services Corporation (LINC) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +19.05%. A quarter ago, it was expected that this company would post earnings of $0.12 per share when it actually produced earnings of $0.2, delivering a surprise of +66.67%.Over the last fo ...

分组1 - ImmunityBio reported a quarterly loss of $0.06 per share, better than the Zacks Consensus Estimate of a loss of $0.08, and improved from a loss of $0.15 per share a year ago, resulting in an earnings surprise of +25.00% [1] - The company achieved revenues of $38.29 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 3.19%, and significantly up from $7.55 million in the same quarter last year [2] - ImmunityBio's stock has increased approximately 339.4% since the beginning of the year, outperforming the S&P 500's gain of 0.9% [3] 分组2 - The earnings outlook for ImmunityBio is crucial for investors, with current consensus EPS estimates at -$0.08 for the coming quarter and -$0.32 for the current fiscal year, alongside expected revenues of $41.75 million and $205.6 million respectively [7] - The Zacks Industry Rank places the Medical - Biomedical and Genetics sector in the top 37% of over 250 Zacks industries, indicating a favorable environment for stocks in this sector [8] - Intellia Therapeutics, another company in the same industry, is expected to report a quarterly loss of $0.99 per share, reflecting a year-over-year change of +20.2%, with revenues anticipated to be $11.85 million, down 7.9% from the previous year [9][10]

Core Viewpoint - Fractyl Health, Inc. (GUTS) has experienced a significant decline of 77.6% in its stock price over the past four weeks, but it is now in oversold territory, suggesting a potential for a turnaround as analysts expect better earnings than previously predicted [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a momentum oscillator that indicates whether a stock is oversold, with readings below 30 typically signaling this condition [2]. - GUTS has an RSI reading of 24.79, indicating that the heavy selling pressure may be exhausting, which could lead to a price rebound [5]. - The RSI helps investors identify potential entry points for stocks that have fallen below their fair value due to excessive selling [3]. Group 2: Fundamental Indicators - Analysts covering GUTS have raised their earnings estimates for the current year, resulting in a 1.8% increase in the consensus EPS estimate over the last 30 days, which often correlates with price appreciation [7]. - GUTS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a near-term turnaround [8].

Noble Corporation PLC (NE) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in ea ...

Core Viewpoint - Rush Street Interactive, Inc. (RSI) shows a significantly improving earnings outlook, making it a solid investment choice as analysts continue to raise earnings estimates for the company [1][3]. Earnings Estimate Revisions - The rising trend in earnings estimate revisions reflects growing analyst optimism, which is expected to positively impact the stock price [2]. - The current quarter's earnings estimate is $0.12 per share, representing a +33.3% change from the previous year, with a 21.43% increase in the Zacks Consensus Estimate over the last 30 days [6]. - For the full year, the expected earnings are $0.53 per share, indicating a +43.2% change from the prior year, with a 13.89% increase in consensus estimates due to two upward revisions [7][8]. Zacks Rank - Rush Street Interactive has achieved a Zacks Rank 2 (Buy), indicating strong agreement among analysts in revising earnings estimates upward, which historically correlates with stock performance [9]. - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have shown significant outperformance compared to the S&P 500 [9]. Investment Outlook - The stock has increased by 5.1% over the past four weeks due to strong estimate revisions, suggesting potential for further upside, making it a candidate for portfolio addition [10].

LCI (LCII) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a changing earnin ...